Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial

INTRODUCTION: Alternatives to carbapenems are needed in the treatment of third-generation cephalosporin-resistant Enterobacterales (3GCR-E). Temocillin is a suitable candidate, but comparative randomised studies are lacking. The objective is to investigate if temocillin is non-inferior to carbapenem...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Candón, Alicia, Rosso-Fernández, Clara M, Bustos de Godoy, Natalia, López-Cerero, Lorena, Gutiérrez-Gutiérrez, Belén, López-Cortés, Luis Eduardo, Barrera Pulido, Lydia, Borreguero Borreguero, Irene, León, María José, Merino, Vicente, Camean-Fernández, Manuel, Retamar, Pilar, Salamanca, Elena, Pascual, Alvaro, Rodriguez-Baño, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477313/
https://www.ncbi.nlm.nih.gov/pubmed/34580096
http://dx.doi.org/10.1136/bmjopen-2021-049481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477313/
https://www.ncbi.nlm.nih.gov/pubmed/34580096
http://dx.doi.org/10.1136/bmjopen-2021-049481

Ejemplares similares